Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (601-610 of 1,398) with videos related to

Pageof 140
Sort By:
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Oncogene|May 23, 2003
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsChristiane Knuefermann, Yang Lu, Bolin Liu, et al.
Proteomics|July 11, 2008
Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancerTobias Grote, Doris R Siwak, Herbert A Fritsche, et al.
Blood|October 9, 2008
Functional proteomic profiling of AML predicts response and survivalSteven M Kornblau, Raoul Tibes, Yi Hua Qiu, et al.
Plos One|April 3, 2010
Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinaseZhiyong Ding, Jiyong Liang, Jin Li, et al.
Oncogene|August 18, 2015
PKCiota promotes ovarian tumor progression through deregulation of cyclin EA Nanos-Webb, T Bui, C Karakas, et al.
Journal of Cancer|November 5, 2014
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJoohyuk Sohn, Shuying Liu, Napa Parinyanitikul, et al.
Genome Biology|February 22, 2020
Comprehensive assessment of computational algorithms in predicting cancer driver mutationsHu Chen, Jun Li, Yumeng Wang, et al.
Plos One|July 2, 2014
AKT pathway genes define 5 prognostic subgroups in glioblastomaAnna Joy, Archana Ramesh, Ivan Smirnov, et al.
Molecular Cancer Therapeutics|November 9, 2005
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.
Pageof 140

Showing results (601-610 of 1,398) with videos related to

Sort By:
Pageof 140
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Oncogene|May 23, 2003
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsChristiane Knuefermann, Yang Lu, Bolin Liu, et al.
Proteomics|July 11, 2008
Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancerTobias Grote, Doris R Siwak, Herbert A Fritsche, et al.
Blood|October 9, 2008
Functional proteomic profiling of AML predicts response and survivalSteven M Kornblau, Raoul Tibes, Yi Hua Qiu, et al.
Plos One|April 3, 2010
Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinaseZhiyong Ding, Jiyong Liang, Jin Li, et al.
Oncogene|August 18, 2015
PKCiota promotes ovarian tumor progression through deregulation of cyclin EA Nanos-Webb, T Bui, C Karakas, et al.
Journal of Cancer|November 5, 2014
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJoohyuk Sohn, Shuying Liu, Napa Parinyanitikul, et al.
Genome Biology|February 22, 2020
Comprehensive assessment of computational algorithms in predicting cancer driver mutationsHu Chen, Jun Li, Yumeng Wang, et al.
Plos One|July 2, 2014
AKT pathway genes define 5 prognostic subgroups in glioblastomaAnna Joy, Archana Ramesh, Ivan Smirnov, et al.
Molecular Cancer Therapeutics|November 9, 2005
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.
Pageof 140